i want ppt of golmerularnephritis

Asking for Preferences
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
general-purpose

Create a PowerPoint presentation (.pptx) file on **Glomerulonephritis** for medical students at an overview/basic level. Save it to `/home/user/Glomerulonephritis.pptx`. Use the `python-pptx` library to generate the file programmatically. Write and execute a Python script to create the PPTX. Here is the full content to include across slides: --- **SLIDE 1 – Title Slide** Title: Glomerulonephritis (GN) Subtitle: An Overview for Medical Students Footer: Sources: Harrison's Principles of Internal Medicine 22E; Comprehensive Clinical Nephrology, 7th Ed. --- **SLIDE 2 – What is Glomerulonephritis?** - Inflammation of the glomeruli — the filtering units of the kidney - Leads to impaired filtration, proteinuria, hematuria, and renal dysfunction - Can be primary (idiopathic) or secondary (due to systemic disease, infection, autoimmune) - Presents as acute, subacute (days–weeks), or chronic (months–years) disease - Early diagnosis is critical to prevent progression to chronic kidney failure --- **SLIDE 3 – Glomerular Anatomy (Quick Review)** - Each kidney contains ~1 million nephrons - Glomerulus = a tuft of capillaries enclosed in Bowman's capsule - Key cell types: Endothelial cells, Mesangial cells, Podocytes - Glomerular Basement Membrane (GBM) — made of Type IV collagen (α3:α4:α5) - Slit-pore membrane (nephrin, podocin) acts as a protein filter - Damage to any of these components → glomerular disease --- **SLIDE 4 – Clinical Presentation** Two main syndromes: **Nephritic Syndrome:** - Hematuria (cola/tea-colored urine — "macroscopic hematuria") - Hypertension - Oliguria / Anuria - Mild-to-moderate proteinuria - Edema - Dysmorphic RBCs and RBC casts on urinalysis — hallmark finding **Nephrotic Syndrome:** - Heavy proteinuria (>3.5 g/day) - Hypoalbuminemia - Edema - Hyperlipidemia / Lipiduria --- **SLIDE 5 – Urinalysis in GN** - Spun urinary sediment is essential to diagnose active GN - Key findings: • Hematuria — microscopic or macroscopic • Dysmorphic red blood cells (RBCs cross glomerular membrane → misshapen) • RBC casts → strongly suggest glomerular origin of hematuria • Pyuria (WBCs) • Proteinuria - Macroscopic hematuria: "cola" or "tea-colored" urine from hematin formation in acid urine - IgA nephropathy: may show gross red hematuria --- **SLIDE 6 – Classification of GN** **By Onset:** - Acute GN — sudden onset (e.g., Postinfectious GN) - Rapidly Progressive GN (RPGN) — rapid decline in renal function over days–weeks - Chronic GN — gradual progression over months–years **By Pathogenesis (3 major categories of RPGN):** 1. ANCA-positive vasculitis (pauci-immune) 2. Anti-GBM antibody disease (Goodpasture disease) 3. Immune complex-mediated (low C3) — IgA nephropathy, PSGN, SLE, MPGN --- **SLIDE 7 – Postinfectious GN (PSGN)** - Classic example of acute GN - Caused by nephritogenic strains of Group A β-hemolytic Streptococcus - Occurs 10 days–3 weeks after pharyngeal or skin (impetigo) infection - Mechanism: Immune complex deposition → complement activation → inflammation - Mostly affects children (5–15 years) - Clinical: Hematuria, hypertension, edema, oliguria, ↓C3 - Investigations: ↑ASO titer, ↓C3, positive throat/skin culture - Prognosis: Most children recover fully; worse prognosis in adults --- **SLIDE 8 – IgA Nephropathy (Berger Disease)** - Most common primary GN worldwide - Pathology: Mesangial IgA deposits - Trigger: Mucosal infections (respiratory, GI) → episodes of gross hematuria - Presents: Recurrent macroscopic hematuria (often after URTI, within 1–2 days) - Urinalysis: Dysmorphic RBCs, RBC casts - Diagnosis: Renal biopsy (mesangial IgA on immunofluorescence) - Treatment: ACE inhibitors, corticosteroids in progressive cases - Course: 20–40% progress to ESRD over 20 years --- **SLIDE 9 – Rapidly Progressive GN (RPGN)** - Medical emergency — rapid loss of renal function over days to weeks - Pathology: Crescents in >50% of glomeruli (crescentic GN) - Three types: 1. Type I — Anti-GBM (linear IgG on IF) — Goodpasture disease 2. Type II — Immune complex (granular IgG on IF) — SLE, PSGN, IgA 3. Type III — Pauci-immune (ANCA-positive) — GPA, MPA - Treatment: Urgent high-dose steroids ± cyclophosphamide; plasmapheresis for Type I --- **SLIDE 10 – Secondary Causes of GN** | Cause | Type of GN | |---|---| | SLE | Lupus nephritis (Class III/IV most severe) | | Hepatitis B | Membranous GN, MPGN | | Hepatitis C | MPGN, Cryoglobulinemic GN | | Diabetes | Diabetic nephropathy | | ANCA vasculitis | Crescentic (Pauci-immune) GN | | Anti-GBM | Goodpasture disease | --- **SLIDE 11 – Investigations** | Test | Finding/Purpose | |---|---| | Urinalysis + Microscopy | RBCs, RBC casts, proteinuria | | 24h urine protein | Quantify proteinuria | | Serum creatinine/BUN | Assess renal function | | Complement (C3, C4) | Low in PSGN, SLE, MPGN | | ASO titer | Post-streptococcal GN | | ANA, anti-dsDNA | SLE | | ANCA (c-ANCA, p-ANCA) | Vasculitis | | Anti-GBM antibodies | Goodpasture disease | | Renal Biopsy | Gold standard for diagnosis | --- **SLIDE 12 – Management Overview** **General measures:** - Blood pressure control (ACE inhibitors / ARBs) - Salt and fluid restriction - Treat underlying cause **Specific:** - PSGN: Antibiotics for active infection; supportive care (most self-limiting) - IgA nephropathy: ACE-I/ARB; steroids for persistent proteinuria - RPGN: Pulse IV methylprednisolone + cyclophosphamide; plasmapheresis (anti-GBM) - Lupus nephritis: Steroids + MMF or cyclophosphamide **Dialysis** if ESRD develops --- **SLIDE 13 – Summary** - GN = glomerular inflammation → hematuria, proteinuria, hypertension, ↓GFR - Hallmark urinalysis: RBC casts + dysmorphic RBCs - Main categories: Postinfectious, IgA, RPGN, Lupus nephritis - RPGN is a medical emergency — crescents on biopsy - Three RPGN types: Anti-GBM | Immune complex | Pauci-immune (ANCA) - Treatment depends on type: Steroids, cyclophosphamide, plasmapheresis - Renal biopsy = gold standard for diagnosis --- **SLIDE 14 – References** - Harrison's Principles of Internal Medicine, 22nd Edition (2025), McGraw Hill - Comprehensive Clinical Nephrology, 7th Edition — Elsevier - Swanson's Family Medicine Review --- **Design instructions:** - Use a clean, professional medical theme with a blue/navy color scheme - Title slide: dark blue background, white text - Content slides: white background, dark blue headings, black body text - Use bullet points clearly with adequate font size (28–32pt for headings, 18–20pt for body) - Use tables where indicated - Add slide numbers to all slides - The presentation should have 14 slides total Save the file as `/home/user/Glomerulonephritis.pptx` After creating the file, confirm its path and file size.

Writing File

/home/user/make_gn_ppt.py


from pptx import Presentation
from pptx.util import Inches, Pt, Emu
from pptx.dml.color import RGBColor
from pptx.enum.text import PP_ALIGN
from pptx.util import Inches, Pt
from pptx.oxml.ns import qn
from lxml import etree
import copy

prs = Presentation()
prs.slide_width = Inches(13.33)
prs.slide_height = Inches(7.5)

NAVY = RGBColor(0x00, 0x33, 0x6A)
WHITE = RGBColor(0xFF, 0xFF, 0xFF)
LIGHT_BLUE = RGBColor(0xD6, 0xE4, 0xF0)
BLACK = RGBColor(0x1A, 0x1A, 0x2E)
ACCENT = RGBColor(0x00, 0x86, 0xC8)

blank_layout = prs.slide_layouts[6]  # blank

def add_rect(slide, left, top, width, height, fill_color=None, line_color=None):
    shape = slide.shapes.add_shape(1, Inches(left), Inches(top), Inches(width), Inches(height))
    if fill_color:
        shape.fill.solid()
        shape.fill.fore_color.rgb = fill_color
    else:
        shape.fill.background()
    if line_color:
        shape.line.color.rgb = line_color
        shape.line.width = Pt(1)
    else:
        shape.line.fill.background()
    return shape

def add_textbox(slide, text, left, top, width, height, font_size=18, bold=False,
                color=BLACK, align=PP_ALIGN.LEFT, wrap=True):
    txBox = slide.shapes.add_textbox(Inches(left), Inches(top), Inches(width), Inches(height))
    tf = txBox.text_frame
    tf.word_wrap = wrap
    p = tf.paragraphs[0]
    p.alignment = align
    run = p.add_run()
    run.text = text
    run.font.size = Pt(font_size)
    run.font.bold = bold
    run.font.color.rgb = color
    return txBox

def add_slide_number(slide, num):
    txBox = slide.shapes.add_textbox(Inches(12.5), Inches(7.1), Inches(0.7), Inches(0.3))
    tf = txBox.text_frame
    p = tf.paragraphs[0]
    p.alignment = PP_ALIGN.RIGHT
    run = p.add_run()
    run.text = str(num)
    run.font.size = Pt(12)
    run.font.color.rgb = RGBColor(0x88, 0x88, 0x88)

def add_header_bar(slide, title_text, slide_num):
    # Top navy bar
    bar = add_rect(slide, 0, 0, 13.33, 1.1, fill_color=NAVY)
    # Title text
    txBox = slide.shapes.add_textbox(Inches(0.3), Inches(0.1), Inches(12.7), Inches(0.9))
    tf = txBox.text_frame
    tf.word_wrap = True
    p = tf.paragraphs[0]
    p.alignment = PP_ALIGN.LEFT
    run = p.add_run()
    run.text = title_text
    run.font.size = Pt(30)
    run.font.bold = True
    run.font.color.rgb = WHITE
    add_slide_number(slide, slide_num)

def add_bullet_slide(slide, title, bullets, slide_num, cols=1):
    add_header_bar(slide, title, slide_num)
    # White background
    bg = add_rect(slide, 0, 0, 13.33, 7.5, fill_color=WHITE)
    bg.zorder = 0
    add_header_bar(slide, title, slide_num)
    
    top = 1.25
    for bullet in bullets:
        indent = bullet.get('indent', 0)
        text = bullet.get('text', '')
        is_header = bullet.get('header', False)
        left = 0.4 + indent * 0.35
        width = 12.5 - indent * 0.35
        
        if is_header:
            txBox = slide.shapes.add_textbox(Inches(left), Inches(top), Inches(width), Inches(0.45))
            tf = txBox.text_frame
            tf.word_wrap = True
            p = tf.paragraphs[0]
            run = p.add_run()
            run.text = text
            run.font.size = Pt(20)
            run.font.bold = True
            run.font.color.rgb = ACCENT
            top += 0.42
        else:
            # bullet point
            prefix = "  " * indent + ("• " if indent == 0 else "◦ ")
            txBox = slide.shapes.add_textbox(Inches(left), Inches(top), Inches(width), Inches(0.38))
            tf = txBox.text_frame
            tf.word_wrap = True
            p = tf.paragraphs[0]
            run = p.add_run()
            run.text = prefix + text
            run.font.size = Pt(18)
            run.font.bold = False
            run.font.color.rgb = BLACK
            top += 0.36
    return slide

def add_table_slide(slide, title, headers, rows, slide_num):
    add_header_bar(slide, title, slide_num)
    bg = add_rect(slide, 0, 0, 13.33, 7.5, fill_color=WHITE)
    bg.zorder = 0
    add_header_bar(slide, title, slide_num)
    
    cols = len(headers)
    num_rows = len(rows) + 1
    table = slide.shapes.add_table(num_rows, cols, Inches(0.4), Inches(1.3), Inches(12.5), Inches(0.45 * num_rows)).table
    
    # Header row
    for ci, h in enumerate(headers):
        cell = table.cell(0, ci)
        cell.fill.solid()
        cell.fill.fore_color.rgb = NAVY
        p = cell.text_frame.paragraphs[0]
        run = p.add_run()
        run.text = h
        run.font.size = Pt(17)
        run.font.bold = True
        run.font.color.rgb = WHITE
    
    for ri, row in enumerate(rows):
        for ci, val in enumerate(row):
            cell = table.cell(ri + 1, ci)
            if ri % 2 == 0:
                cell.fill.solid()
                cell.fill.fore_color.rgb = LIGHT_BLUE
            else:
                cell.fill.solid()
                cell.fill.fore_color.rgb = WHITE
            p = cell.text_frame.paragraphs[0]
            run = p.add_run()
            run.text = val
            run.font.size = Pt(15)
            run.font.color.rgb = BLACK

# ─── SLIDE 1: Title ───────────────────────────────────────────────────────────
slide1 = prs.slides.add_slide(blank_layout)
bg1 = add_rect(slide1, 0, 0, 13.33, 7.5, fill_color=NAVY)

# Decorative accent
add_rect(slide1, 0, 5.8, 13.33, 0.12, fill_color=ACCENT)
add_rect(slide1, 0, 5.92, 13.33, 1.58, fill_color=RGBColor(0x00, 0x1A, 0x40))

txBox = slide1.shapes.add_textbox(Inches(1), Inches(1.5), Inches(11), Inches(2.2))
tf = txBox.text_frame
tf.word_wrap = True
p = tf.paragraphs[0]
p.alignment = PP_ALIGN.CENTER
run = p.add_run()
run.text = "Glomerulonephritis (GN)"
run.font.size = Pt(52)
run.font.bold = True
run.font.color.rgb = WHITE

txBox2 = slide1.shapes.add_textbox(Inches(1), Inches(3.5), Inches(11), Inches(0.6))
tf2 = txBox2.text_frame
p2 = tf2.paragraphs[0]
p2.alignment = PP_ALIGN.CENTER
run2 = p2.add_run()
run2.text = "An Overview for Medical Students"
run2.font.size = Pt(26)
run2.font.color.rgb = LIGHT_BLUE

txBox3 = slide1.shapes.add_textbox(Inches(1), Inches(6.1), Inches(11), Inches(0.5))
tf3 = txBox3.text_frame
p3 = tf3.paragraphs[0]
p3.alignment = PP_ALIGN.CENTER
run3 = p3.add_run()
run3.text = "Sources: Harrison's Principles of Internal Medicine 22E  |  Comprehensive Clinical Nephrology, 7th Ed."
run3.font.size = Pt(13)
run3.font.color.rgb = RGBColor(0xAA, 0xCC, 0xEE)
add_slide_number(slide1, 1)

# ─── SLIDE 2: What is GN ─────────────────────────────────────────────────────
slide2 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide2, "What is Glomerulonephritis?", [
    {'text': 'Inflammation of the glomeruli — the microscopic filtering units of the kidney'},
    {'text': 'Results in impaired filtration → proteinuria, hematuria, and renal dysfunction'},
    {'text': 'Can be primary (idiopathic) or secondary (systemic disease, infection, autoimmune)'},
    {'text': 'Presentation:'},
    {'text': 'Acute (sudden onset)', 'indent': 1},
    {'text': 'Subacute (days to weeks)', 'indent': 1},
    {'text': 'Chronic (months to years — progressive)', 'indent': 1},
    {'text': 'Early diagnosis is critical to prevent progression to chronic kidney failure'},
    {'text': 'Volume expansion → edema, hypertension; oliguria/anuria common'},
], 2)

# ─── SLIDE 3: Glomerular Anatomy ─────────────────────────────────────────────
slide3 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide3, "Glomerular Anatomy — Quick Review", [
    {'text': 'Each kidney has ~1 million nephrons'},
    {'text': 'Glomerulus = tuft of capillaries enclosed in Bowman's capsule'},
    {'text': 'Key cell types:'},
    {'text': 'Endothelial cells (fenestrated) — allow fluid filtration', 'indent': 1},
    {'text': 'Mesangial cells — structural support, phagocytic function', 'indent': 1},
    {'text': 'Podocytes — wrap around capillaries; form slit-pore membrane', 'indent': 1},
    {'text': 'Glomerular Basement Membrane (GBM): Type IV collagen (α3:α4:α5)'},
    {'text': 'Slit-pore membrane proteins: Nephrin, Podocin — act as protein size filter'},
    {'text': 'Damage to any component → glomerular disease (proteinuria, hematuria)'},
], 3)

# ─── SLIDE 4: Clinical Presentation ─────────────────────────────────────────
slide4 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide4, "Clinical Presentation", [
    {'text': 'Nephritic Syndrome', 'header': True},
    {'text': 'Hematuria (cola/tea-colored urine — macroscopic hematuria)'},
    {'text': 'Hypertension, Oliguria/Anuria'},
    {'text': 'Mild-to-moderate proteinuria'},
    {'text': 'Edema (periorbital, peripheral, ascites in children)'},
    {'text': 'Dysmorphic RBCs and RBC casts on urinalysis — hallmark'},
    {'text': 'Nephrotic Syndrome', 'header': True},
    {'text': 'Heavy proteinuria (>3.5 g/day)'},
    {'text': 'Hypoalbuminemia → edema'},
    {'text': 'Hyperlipidemia and lipiduria'},
    {'text': 'Note: Some GN presents with overlapping features (nephritic-nephrotic)'},
], 4)

# ─── SLIDE 5: Urinalysis ─────────────────────────────────────────────────────
slide5 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide5, "Urinalysis in GN", [
    {'text': 'Spun urinary sediment is ESSENTIAL to diagnose active GN'},
    {'text': 'Key findings:'},
    {'text': 'Hematuria — microscopic or macroscopic', 'indent': 1},
    {'text': 'Dysmorphic RBCs — RBCs distorted as they cross damaged GBM', 'indent': 1},
    {'text': 'RBC casts — strongly suggest glomerular origin of hematuria ★', 'indent': 1},
    {'text': 'Pyuria (WBCs) — mixed inflammatory cells', 'indent': 1},
    {'text': 'Proteinuria', 'indent': 1},
    {'text': 'Macroscopic hematuria: "cola" or "tea-colored" urine'},
    {'text': '  → Hematin forms when hemoglobin enters acidic urine'},
    {'text': 'IgA nephropathy: gross RED hematuria (RBCs cross diseased GBM)'},
    {'text': 'Blood clots or grossly red urine → consider lower urinary tract cause'},
], 5)

# ─── SLIDE 6: Classification ─────────────────────────────────────────────────
slide6 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide6, "Classification of GN", [
    {'text': 'By Onset / Course', 'header': True},
    {'text': 'Acute GN — sudden onset (e.g., Post-streptococcal GN)'},
    {'text': 'Rapidly Progressive GN (RPGN) — rapid decline over days–weeks'},
    {'text': 'Chronic GN — gradual progression over months–years'},
    {'text': '3 Major Pathogenic Categories (RPGN)', 'header': True},
    {'text': 'Type I — Anti-GBM antibody disease (Goodpasture disease)'},
    {'text': 'Type II — Immune complex-mediated (low C3) — IgA, PSGN, SLE, MPGN'},
    {'text': 'Type III — Pauci-immune / ANCA-positive — GPA (Wegener), MPA'},
    {'text': 'Primary vs Secondary', 'header': True},
    {'text': 'Primary: Idiopathic — IgA nephropathy, FSGS, Minimal change'},
    {'text': 'Secondary: SLE, Diabetes, Vasculitis, Infections (Hep B/C, HIV)'},
], 6)

# ─── SLIDE 7: PSGN ───────────────────────────────────────────────────────────
slide7 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide7, "Postinfectious GN (PSGN)", [
    {'text': 'Classic example of acute GN'},
    {'text': 'Cause: Nephritogenic strains of Group A β-hemolytic Streptococcus'},
    {'text': 'Latent period: 10 days–3 weeks after pharyngeal or skin (impetigo) infection'},
    {'text': 'Mechanism: Immune complex (Ag-Ab) deposition → complement activation → inflammation'},
    {'text': 'Mainly affects children (5–15 years)'},
    {'text': 'Clinical features:'},
    {'text': 'Hematuria, hypertension, periorbital edema, oliguria', 'indent': 1},
    {'text': 'Investigations:'},
    {'text': '↑ ASO titer (pharyngeal infection)', 'indent': 1},
    {'text': '↓ C3 complement', 'indent': 1},
    {'text': 'Positive throat / skin culture', 'indent': 1},
    {'text': 'Prognosis: Children — excellent recovery; Adults — worse prognosis'},
], 7)

# ─── SLIDE 8: IgA Nephropathy ────────────────────────────────────────────────
slide8 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide8, "IgA Nephropathy (Berger Disease)", [
    {'text': 'Most common primary GN worldwide'},
    {'text': 'Pathology: Mesangial IgA immune complex deposits'},
    {'text': 'Trigger: Mucosal infections (respiratory, GI) → IgA overproduction'},
    {'text': 'Presentation: Recurrent GROSS hematuria, typically 1–2 days after URTI'},
    {'text': 'Urinalysis: Dysmorphic RBCs, RBC casts'},
    {'text': 'Diagnosis: Renal biopsy — mesangial IgA on immunofluorescence (gold standard)'},
    {'text': 'Treatment:'},
    {'text': 'ACE inhibitors / ARBs — first line (proteinuria reduction)', 'indent': 1},
    {'text': 'Corticosteroids for persistent significant proteinuria', 'indent': 1},
    {'text': 'Course: 20–40% progress to ESRD over 20 years'},
], 8)

# ─── SLIDE 9: RPGN ───────────────────────────────────────────────────────────
slide9 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide9, "Rapidly Progressive GN (RPGN)", [
    {'text': '⚠ Medical emergency — rapid loss of renal function over days to weeks'},
    {'text': 'Pathology: Crescents in >50% of glomeruli (crescentic GN) on biopsy'},
    {'text': 'Three Types:', 'header': True},
    {'text': 'Type I — Anti-GBM (Goodpasture disease)'},
    {'text': '  Linear IgG deposition on immunofluorescence'},
    {'text': '  May have lung hemorrhage (pulmonary-renal syndrome)'},
    {'text': 'Type II — Immune Complex (SLE, PSGN, IgA, MPGN)'},
    {'text': '  Granular IgG deposition on immunofluorescence'},
    {'text': 'Type III — Pauci-immune (ANCA vasculitis — GPA, MPA)'},
    {'text': '  Negative/scant IF, ANCA positive in blood'},
    {'text': 'Treatment:', 'header': True},
    {'text': 'High-dose IV methylprednisolone + cyclophosphamide'},
    {'text': 'Plasmapheresis for Type I (anti-GBM) and severe ANCA'},
], 9)

# ─── SLIDE 10: Secondary Causes — TABLE ──────────────────────────────────────
slide10 = prs.slides.add_slide(blank_layout)
add_table_slide(slide10,
    "Secondary Causes of GN",
    ["Underlying Cause", "Type of GN"],
    [
        ["Systemic Lupus Erythematosus (SLE)", "Lupus nephritis (Class III/IV most severe)"],
        ["Hepatitis B", "Membranous GN, MPGN"],
        ["Hepatitis C", "MPGN, Cryoglobulinemic GN"],
        ["Diabetes Mellitus", "Diabetic nephropathy"],
        ["ANCA-associated vasculitis (GPA, MPA)", "Crescentic (Pauci-immune) GN"],
        ["Anti-GBM antibodies", "Goodpasture disease"],
        ["Schistosomiasis", "Immune-mediated GN, AA amyloidosis"],
        ["Post-streptococcal infection", "Proliferative / Endocapillary GN"],
    ],
    10
)

# ─── SLIDE 11: Investigations — TABLE ────────────────────────────────────────
slide11 = prs.slides.add_slide(blank_layout)
add_table_slide(slide11,
    "Investigations",
    ["Test", "Finding / Purpose"],
    [
        ["Urinalysis + Microscopy", "RBCs, RBC casts, proteinuria — diagnose active GN"],
        ["24-hour urine protein", "Quantify proteinuria"],
        ["Serum creatinine / BUN", "Assess renal function"],
        ["Complement (C3, C4)", "↓ in PSGN, SLE, MPGN"],
        ["ASO titer", "Post-streptococcal GN"],
        ["ANA, Anti-dsDNA", "SLE / Lupus nephritis"],
        ["ANCA (c-ANCA, p-ANCA)", "ANCA vasculitis (GPA, MPA)"],
        ["Anti-GBM antibodies", "Goodpasture disease"],
        ["Renal Biopsy", "Gold standard — definitive diagnosis and classification"],
    ],
    11
)

# ─── SLIDE 12: Management ─────────────────────────────────────────────────────
slide12 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide12, "Management Overview", [
    {'text': 'General Measures', 'header': True},
    {'text': 'Blood pressure control — ACE inhibitors / ARBs (renoprotective)'},
    {'text': 'Salt and fluid restriction'},
    {'text': 'Treat underlying cause'},
    {'text': 'Specific Treatment by Type', 'header': True},
    {'text': 'PSGN: Antibiotics for active infection; supportive (mostly self-limiting)'},
    {'text': 'IgA nephropathy: ACE-I/ARB; corticosteroids for persistent proteinuria'},
    {'text': 'RPGN: Pulse IV methylprednisolone + cyclophosphamide'},
    {'text': 'Anti-GBM (Type I RPGN): + Plasmapheresis to remove circulating antibodies'},
    {'text': 'Lupus nephritis: Steroids + MMF or cyclophosphamide'},
    {'text': 'Dialysis / Renal replacement therapy if ESRD develops'},
], 12)

# ─── SLIDE 13: Summary ────────────────────────────────────────────────────────
slide13 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide13, "Summary", [
    {'text': 'GN = glomerular inflammation → hematuria, proteinuria, hypertension, ↓ GFR'},
    {'text': 'Hallmark urinalysis: RBC casts + dysmorphic RBCs'},
    {'text': 'Main syndromes: Nephritic vs Nephrotic (can overlap)'},
    {'text': 'Key types: Postinfectious GN | IgA Nephropathy | RPGN | Lupus nephritis'},
    {'text': 'RPGN = medical emergency — crescents on biopsy'},
    {'text': 'Three RPGN types:'},
    {'text': 'Anti-GBM (Type I)', 'indent': 1},
    {'text': 'Immune complex (Type II)', 'indent': 1},
    {'text': 'Pauci-immune / ANCA (Type III)', 'indent': 1},
    {'text': 'Renal biopsy = gold standard for diagnosis'},
    {'text': 'Treatment: Steroids ± cyclophosphamide ± plasmapheresis (based on type)'},
], 13)

# ─── SLIDE 14: References ────────────────────────────────────────────────────
slide14 = prs.slides.add_slide(blank_layout)
add_bullet_slide(slide14, "References", [
    {'text': 'Harrison\'s Principles of Internal Medicine, 22nd Edition (2025)'},
    {'text': '  McGraw Hill Medical — Chapter 319: Glomerulonephritis'},
    {'text': 'Comprehensive Clinical Nephrology, 7th Edition'},
    {'text': '  Elsevier — Chapters 25, 57'},
    {'text': 'Swanson\'s Family Medicine Review (2021), Elsevier'},
    {'text': 'Campbell Walsh Wein Urology, 3-Volume Set — Elsevier'},
    {'text': 'Brenner and Rector\'s The Kidney, 2-Volume Set — Elsevier'},
], 14)

# Save
path = '/home/user/Glomerulonephritis.pptx'
prs.save(path)
import os
size = os.path.getsize(path)
print(f"Saved: {path} ({size:,} bytes)")
Finding Files

*.py in /home/user

Model call limits exceeded: run limit (10/10)

disease overview or introduction to glomerulonephritis

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Loading Image
I now have all the content needed for a comprehensive introduction. Here is the full disease overview:

Glomerulonephritis (GN) — Disease Overview & Introduction


1. Definition

Glomerulonephritis refers to a group of disorders characterized by inflammation of the glomeruli — the microscopic capillary tufts within the kidney responsible for filtering blood. The presentations range widely: from an asymptomatic individual found incidentally to have hematuria or proteinuria on a routine check, to a fulminant illness with acute kidney injury (AKI) and life-threatening extrarenal disease.
The most dramatic symptomatic presentations are actually uncommon. Asymptomatic urine abnormalities are far more frequent, though they may indicate a wide range of glomerular or non-glomerular diseases.
Comprehensive Clinical Nephrology, 7th Edition, p. 234

2. The Glomerulus — What Is Being Inflamed?

Each kidney contains approximately 1 million nephrons, each with a glomerulus at its head. The glomerulus consists of:
ComponentStructure & Role
Fenestrated endotheliumLines capillaries; allows fluid filtration
Glomerular Basement Membrane (GBM)Type IV collagen network (α3:α4:α5); structural scaffold
PodocytesEpithelial cells with foot processes; form the slit-pore membrane
Mesangial cellsStructural support; phagocytic; contractile
The slit-pore membrane between adjacent podocyte foot processes — formed by proteins including nephrin, podocin, CD2AP, and TRPC6 — acts as the final protein size filter. Damage to any of these components leads to proteinuria or hematuria.
Podocytes attach to the GBM by special foot processes and are replenished by migrating parietal epithelial cells from Bowman's capsule; impaired replenishment results in heavy proteinuria.
Harrison's Principles of Internal Medicine 22E, p. 2407

3. How GN Presents Clinically

GN is associated with three core features:
Hypertension + Volume expansion + Abnormal urinalysis

Volume expansion manifestations:

  • Adults: Edema (peripheral, periorbital), hypertension, orthopnea, dyspnea on exertion
  • Children: Ascites may develop
  • Elderly: Restlessness and anxiety may be the first signs of incipient acute pulmonary edema

Urinary findings:

  • Oliguria (low urine output) or rarely anuria
  • Low urine sodium + concentrated urine → salt and water retention
  • Spun urinary sediment examination is ESSENTIAL to diagnose active GN
The nephritic urinalysis shows:
  • Hematuria (microscopic or macroscopic)
  • Proteinuria
  • Dysmorphic red blood cells — RBCs become misshapen as they cross the damaged GBM
  • RBC casts — the hallmark of glomerular origin of bleeding
  • Mixed inflammatory cells including PMN leukocytes (pyuria)
Macroscopic hematuria: described as "cola" or "tea-colored" urine — hemoglobin enters acid urine and forms hematin. This is classic in post-streptococcal GN and IgA nephropathy (IgA can produce frank red blood-red urine).
Blood clots or overtly blood-red urine accompanied by dysuria → suggests a lower urinary tract source, not glomerular.
Harrison's Principles of Internal Medicine 22E, p. 2406

4. Primary vs Secondary GN

Primary (Idiopathic) GN — no underlying systemic disease identified:
  • IgA Nephropathy (most common worldwide)
  • Minimal Change Disease
  • Focal Segmental Glomerulosclerosis (FSGS)
  • Membranous Nephropathy
  • MPGN (Membranoproliferative GN)
Secondary GN — caused by or associated with:
  • Autoimmune: SLE (lupus nephritis), vasculitis (ANCA-associated)
  • Infections: Post-streptococcal, hepatitis B/C, HIV, endocarditis
  • Metabolic: Diabetes mellitus, amyloidosis
  • Malignancy: Lung/breast/GI adenocarcinoma → membranous nephropathy; Hodgkin disease → minimal change; Non-Hodgkin lymphoma → MPGN
  • Drugs/toxins: NSAIDs, penicillamine, pamidronate, heroin, cyclosporine
  • Genetic: Alport syndrome, mutations in podocin/nephrin (FSGS)
  • Obesity: Morbid obesity → secondary FSGS
Kidney disease is occasionally the first manifestation of an underlying tumor.
Comprehensive Clinical Nephrology, 7th Edition, p. 234

5. Classification by Course

TypeOnsetTimeframeExample
Acute GNSuddenDays to weeksPost-streptococcal GN
Rapidly Progressive GN (RPGN)Rapid deteriorationDays to weeksCrescentic GN, Goodpasture
Chronic GNSmoldering, insidiousMonths to yearsIgA nephropathy, Lupus nephritis
The pathologic correlate of this spectrum — from acute inflammatory/proliferative/necrotizing lesions to chronic sclerotic/atrophic changes on biopsy — reflects the acuity vs. chronicity of the disease. Early diagnosis is therefore critical, as treatment of acute reversible disease must be instituted as quickly as possible.

6. RPGN — Classification by Immunopathology

The most urgent category is Rapidly Progressive Glomerulonephritis (RPGN), classified into three types based on immunofluorescence and serology:
RPGN Classification Diagram
TypeMechanismIF PatternExamples
Type IAnti-GBM antibodiesLinear IgGGoodpasture disease (renal-limited or with lung hemorrhage)
Type IIImmune complexGranular IgGPSGN, SLE, IgA nephropathy, MPGN, SBE, Hepatitis B/C
Type IIIPauci-immune (ANCA+)Scant/negativeGPA (Granulomatosis with polyangiitis), Microscopic polyangiitis
C3 is synthesized in the liver, bound to circulating infectious or neoplastic antigens with their antibody complexes, and deposited in the glomerular subendothelium — explaining why immune complex GN is associated with low C3. Cryoglobulinemia (hepatitis C/myeloma) often lowers C4 as well.
Harrison's Principles of Internal Medicine 22E, Fig. 319-1

7. Clinical Evaluation Framework

History, physical examination, and investigations aim at three goals:
  1. Exclude non-glomerular disease (e.g., UTI, lower tract bleeding)
  2. Find evidence of associated multisystem disease (diabetes, SLE, vasculitis, amyloid)
  3. Establish kidney function (creatinine, eGFR, urinalysis)
Key clinical clues:
  • Hearing loss → Alport syndrome
  • Recent URTI + hematuria within 1–2 days → IgA nephropathy
  • Hematuria 2–3 weeks after throat/skin infection → Post-streptococcal GN
  • Hemoptysis + hematuria → Goodpasture disease or ANCA vasculitis
  • Butterfly rash + joint pains → SLE/lupus nephritis
  • Foamy urine + edema → Heavy proteinuria / nephrotic component

8. The Two Major Clinical Syndromes

FeatureNephritic SyndromeNephrotic Syndrome
HematuriaYes (prominent)Mild or absent
ProteinuriaMild–moderateHeavy (>3.5 g/day)
HypertensionCommonVariable
EdemaYesYes (severe)
HypoalbuminemiaMildSevere
Hyperlipidemia / LipiduriaNoYes
HallmarkRBC casts, dysmorphic RBCsFrothy urine, anasarca
Many forms of GN present with overlapping nephritic-nephrotic features, particularly IgA nephropathy and lupus nephritis.

9. Why Classification Is Challenging

Classification of GN has been difficult because of overlapping features between infection-related and immunologically mediated pathology. There is no single clinical, laboratory, or imaging finding that reliably distinguishes all forms — renal biopsy with light microscopy, immunofluorescence (IF), and electron microscopy (EM) remains the gold standard for definitive diagnosis and classification.

Summary Table

FeatureDetail
DefinitionGlomerular inflammation → impaired filtration
Hallmark urine findingRBC casts + dysmorphic RBCs
Core clinical triadHematuria + Proteinuria + Hypertension
Pathology gold standardRenal biopsy (LM + IF + EM)
Main clinical syndromesNephritic vs Nephrotic (can overlap)
Acute emergencyRPGN — crescents on biopsy
Most common primary GNIgA nephropathy (worldwide)
Classic acute GNPost-streptococcal GN

Sources:
  • Harrison's Principles of Internal Medicine, 22nd Edition (2025) — Chapter 319: Glomerulonephritis
  • Comprehensive Clinical Nephrology, 7th Edition — Chapter 16: Introduction to Glomerular Disease: Clinical Presentations
This is a shared conversation. Sign in to Orris to start your own chat.